By: Natya Hans
With advent of synthetic biology, there have been controversies regarding the patenting of synthetic life forms or techniques to build it. It has impacted both the companies trying to patent, since the shares in market are affected. Following are the links to different cases.
http://www.councilforresponsiblegenetics.org/genewatch/GeneWatchPage.aspx?pageId=346
http://www.genomeweb.com/arrays/how-meeting-munich-and-recent-lawsuit-may-predict-synthetic-bio-market-shake-out
https://theconversation.com/inventing-life-patent-law-and-synthetic-biology-5178
http://www.fool.com/investing/general/2013/05/22/suing-this-synthetic-biology-pioneer-is-silly.aspx
http://www.thecrimson.com/article/2013/7/4/charest-royalties-lawsuit-dispute/
No comments:
Post a Comment